<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Zheng Y</submitter><funding>National Institute of General Medical Sciences</funding><funding>NIGMS NIH HHS</funding><pagination>14006-14014</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9928189</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>12(22)</volume><pubmed_abstract>&lt;i>N&lt;/i>-methylation of peptide backbones has often been utilized as a strategy towards the development of peptidic drugs. However, difficulties in the chemical synthesis, high cost of enantiopure &lt;i>N&lt;/i>-methyl building blocks, and subsequent coupling inefficiencies have hampered larger-scale medicinal chemical efforts. Here, we present a chemoenzymatic strategy for backbone &lt;i>N&lt;/i>-methylation by bioconjugation of peptides of interest to the catalytic scaffold of a borosin-type methyltransferase. Crystal structures of a substrate tolerant enzyme from &lt;i>Mycena rosella&lt;/i> guided the design of a decoupled catalytic scaffold that can be linked via a heterobifunctional crosslinker to any peptide substrate of choice. Peptides linked to the scaffold, including those with non-proteinogenic r</pubmed_abstract><journal>ACS catalysis</journal><pubmed_title>Bioconjugate Platform for Iterative Backbone &lt;i>N&lt;/i>-Methylation of Peptides.</pubmed_title><pmcid>PMC9928189</pmcid><funding_grant_id>R01 GM131347</funding_grant_id><funding_grant_id>R01 GM079038</funding_grant_id><pubmed_authors>Zheng Y</pubmed_authors><pubmed_authors>Ongpipattanakul C</pubmed_authors><pubmed_authors>Nair SK</pubmed_authors></additional><is_claimable>false</is_claimable><name>Bioconjugate Platform for Iterative Backbone &lt;i>N&lt;/i>-Methylation of Peptides.</name><description>&lt;i>N&lt;/i>-methylation of peptide backbones has often been utilized as a strategy towards the development of peptidic drugs. However, difficulties in the chemical synthesis, high cost of enantiopure &lt;i>N&lt;/i>-methyl building blocks, and subsequent coupling inefficiencies have hampered larger-scale medicinal chemical efforts. Here, we present a chemoenzymatic strategy for backbone &lt;i>N&lt;/i>-methylation by bioconjugation of peptides of interest to the catalytic scaffold of a borosin-type methyltransferase. Crystal structures of a substrate tolerant enzyme from &lt;i>Mycena rosella&lt;/i> guided the design of a decoupled catalytic scaffold that can be linked via a heterobifunctional crosslinker to any peptide substrate of choice. Peptides linked to the scaffold, including those with non-proteinogenic r</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Nov</publication><modification>2026-05-28T11:29:15.83Z</modification><creation>2025-02-19T03:27:05.857Z</creation></dates><accession>S-EPMC9928189</accession><cross_references><pubmed>36793448</pubmed><doi>10.1021/acscatal.2c04681</doi></cross_references></HashMap>